| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2018 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INVESCO EXCHANGE TRADED FD T | 22 | Q2 2024 | 9.3% |
| ISHARES TR | 22 | Q2 2024 | 6.8% |
| VANGUARD INDEX FDS | 22 | Q2 2024 | 5.4% |
| VANGUARD INDEX FDS | 22 | Q2 2024 | 4.7% |
| SPDR SER TR | 22 | Q2 2024 | 4.4% |
| APPLE INC | 22 | Q2 2024 | 3.4% |
| DOCUSIGN INC | 22 | Q2 2024 | 7.0% |
| VANGUARD INTL EQUITY INDEX F | 22 | Q2 2024 | 3.0% |
| VANGUARD WHITEHALL FDS INC | 22 | Q2 2024 | 2.9% |
| VANGUARD INDEX FDS | 22 | Q2 2024 | 2.3% |
View SAGE RHINO CAPITAL LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Vincerx Pharma, Inc.Sold out | August 04, 2021 | 0 | 0.0% |
View SAGE RHINO CAPITAL LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-07-30 |
| 13F-HR | 2024-04-26 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-07-31 |
| 13F-HR | 2023-04-21 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-10-24 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-04-27 |
View SAGE RHINO CAPITAL LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.